JP2021530438A5 - - Google Patents
Info
- Publication number
- JP2021530438A5 JP2021530438A5 JP2020567123A JP2020567123A JP2021530438A5 JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5 JP 2020567123 A JP2020567123 A JP 2020567123A JP 2020567123 A JP2020567123 A JP 2020567123A JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- composition according
- seq
- psoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677590P | 2018-05-29 | 2018-05-29 | |
| US62/677,590 | 2018-05-29 | ||
| PCT/US2019/034423 WO2019232070A1 (en) | 2018-05-29 | 2019-05-29 | Compositions and methods for treatment of psoriasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530438A JP2021530438A (ja) | 2021-11-11 |
| JP2021530438A5 true JP2021530438A5 (enExample) | 2022-06-06 |
| JP7357646B2 JP7357646B2 (ja) | 2023-10-06 |
Family
ID=68697289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567123A Active JP7357646B2 (ja) | 2018-05-29 | 2019-05-29 | 乾癬の治療のための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12016921B2 (enExample) |
| EP (1) | EP3801590A4 (enExample) |
| JP (1) | JP7357646B2 (enExample) |
| KR (1) | KR102940600B1 (enExample) |
| CN (1) | CN112689512B (enExample) |
| AU (1) | AU2019279883B2 (enExample) |
| CA (1) | CA3101767A1 (enExample) |
| IL (1) | IL278978B2 (enExample) |
| WO (1) | WO2019232070A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| WO2019232081A1 (en) * | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis |
| WO2019232070A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of psoriasis |
| JP7722989B2 (ja) | 2019-11-12 | 2025-08-13 | アブセントラ，エルエルシー | がんを治療するための方法及び組成物 |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| WO2025151468A1 (en) * | 2024-01-08 | 2025-07-17 | Abcentra, Llc | Methods of identifying a subject for treatment with antibodies against oxidized low density lipoprotein using pericoronary fat attenuation index |
| WO2026064664A1 (en) * | 2024-09-20 | 2026-03-26 | Abcentra, Llc | Antibodies against low density lipoprotein conjugated to a detectable label and uses thereof |
| WO2026165210A1 (en) * | 2025-01-30 | 2026-08-06 | Abcentra, Llc | Treatment regimens for reducing risk of major adverse cardiovascular event |
| WO2026165218A1 (en) * | 2025-01-30 | 2026-08-06 | Abcentra, Llc | Treatment regimens for reducing risk of major adverse cardiovascular event |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103754L (sv) | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| WO2008104194A1 (en) * | 2007-02-28 | 2008-09-04 | Bioinvent International Ab | Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
| AU2008296487A1 (en) | 2007-08-28 | 2009-03-12 | The Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| EP2240156A2 (en) | 2007-12-28 | 2010-10-20 | BioInvent International AB | Antibody-containing formulation for the use for treating cardiovascular diseases associated with atherosclerosis |
| KR20100126515A (ko) * | 2008-03-18 | 2010-12-01 | 아보트 러보러터리즈 | 건선의 치료방법 |
| BR112012007888A2 (pt) | 2009-08-28 | 2019-09-24 | Bioinvent Int | "métodos de tratamento usando anticorpos anti-ldl oxidada". |
| US20120189637A1 (en) * | 2010-10-06 | 2012-07-26 | Valdes Joaquin Mario | Methods for treating psoriasis |
| WO2016024254A1 (en) | 2014-08-15 | 2016-02-18 | Fundació Hospital Universitari Vall D’Hebron-Institut De Recerca | Therapy selection for psoriasis and psoriatic arthritis |
| WO2019232081A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis |
| WO2019232070A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of psoriasis |
-
2019
- 2019-05-29 WO PCT/US2019/034423 patent/WO2019232070A1/en not_active Ceased
- 2019-05-29 CA CA3101767A patent/CA3101767A1/en active Pending
- 2019-05-29 US US17/058,537 patent/US12016921B2/en active Active
- 2019-05-29 KR KR1020207037596A patent/KR102940600B1/ko active Active
- 2019-05-29 IL IL278978A patent/IL278978B2/en unknown
- 2019-05-29 EP EP19811281.5A patent/EP3801590A4/en active Pending
- 2019-05-29 AU AU2019279883A patent/AU2019279883B2/en active Active
- 2019-05-29 CN CN201980050534.6A patent/CN112689512B/zh active Active
- 2019-05-29 JP JP2020567123A patent/JP7357646B2/ja active Active
-
2024
- 2024-06-21 US US18/750,581 patent/US12616749B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240417455A1 (en) | Treatment for rheumatoid arthritis | |
| AU2018200915B2 (en) | Prevention of Adverse Effects Caused by CD3 Specific Binding Domains | |
| JP2023515271A5 (enExample) | ||
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| AU2017201201B2 (en) | Treatment for dermatological pathologies | |
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| JP2022126791A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2023520676A5 (enExample) | ||
| RU2019111921A (ru) | Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r | |
| JP2024530954A5 (enExample) | ||
| JP2017511316A5 (enExample) | ||
| JP2024516698A5 (enExample) | ||
| JP2023545084A5 (enExample) | ||
| JP2024016237A5 (enExample) | ||
| JP2021529766A5 (enExample) | ||
| CN109806393B (zh) | 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途 | |
| CA2865810A1 (en) | Treatment of mucositis with immunoglobulin | |
| JP2024536106A5 (enExample) | ||
| JP2024511079A5 (enExample) | ||
| JP2024522620A5 (enExample) | ||
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| CA2884124C (en) | Treatment for rheumatoid arthritis | |
| Mittal et al. | Monica S. Tandon, Ankit Sharma | |
| RU2024105814A (ru) | Лечение атопического дерматита | |
| TH2101002581A (th) | วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn |